Health & FitnessMental HealthMedicineTechnology

Psychiatry Tomorrow

Osmind

Psychiatry is entering a new era. Join host Carlene MacMillan, M.D., Psychiatrist and Chief Medical Officer at Osmind, for Psychiatry Tomorrow, where we delve into captivating conversations with mental health leaders advancing the field. From groundbreaking research and technology, to the modern private practice and the policies shaping psychiatry’s future.

Navigate the exciting realms of neuromodulation, rapid-acting antidepressants, metabolic psychiatry, psychedelic medicine, starting a private practice, and much more.

Join us on this thrilling journey, and let’s transform mental health together.

Play

Open in

20 episodes
Avg 49 min
English

Episodes 20

Newest Oldest Longest

All20 Unplayed20 In progress0 Played0

#33
Wednesday · 1 hr 7 min
The Interventional Psychiatry Clichés Dr. Lisa Harding Would Kill
Lisa Harding, MD, trained at the top of interventional psychiatry at Yale, then left academia because a hospital is a poor way to get treatments to patients. She joins Will Sauvé and Brittany Albright to argue that the treatments work fine and everything around them, the dosing reflexes, the referral thresholds, the room, and the math, is what fails.
#32
July 29 · 58 min
The Psychiatrist Who Fought the FDA Over How Women's Desire Gets Measured | Anita Clayton, MD
2-sentence description: Dr. Anita Clayton — UVA's chair of psychiatry and the researcher who built the field's standard scale for measuring antidepressant sexual dysfunction — joins Dr. Will Sauvé and Dr. Brittany Albright to trace a career spent proving what drug labels wouldn't say. From a fluoxetine label that said 1.9% when she was seeing 20% in clinic, to fighting the FDA over how women's desire gets measured, to the postpartum and depression treatments she's running trials on right now.
#31
June 4 · 37 min
TMS Works. Almost Nobody Gets It. Scott West, MD on Closing the Gap
Dr. Scott West brought TMS to Tennessee in 2010. Why do so few patients get TMS for treatment-resistant depression, and how can clinicians close the gap?
#30
February 26 · 50 min
A Spravato Patient's Story: From 10 Failed Antidepressants to Marathons and Horror Novels
Hear how one Spravato patient went from cycling through 10 antidepressants to building a life he loves — running marathons, writing novels, and surfing. Ben Leopold shares how the combination of deep therapeutic work and Spravato treatment finally broke through his treatment-resistant depression.
#29
January 21 · 48 min
Why Sleep Is Psychiatry's Blind Spot—And How to Fix It with Avinesh Bhar, MD
Sleep disorders hide behind psychiatric diagnoses. Drs. Avinesh Bhar, Will Sauvé, and Brittany Albright discuss how sleep apnea mimics TRD, anxiety, and ADHD—and what clinicians can do about it.
#28
Nov 5, 2025 · 46 min
Vagal Nerve Stimulation for Depression with Lucian Manu, MD
Vagal nerve stimulation (VNS) treats treatment-resistant depression with unique benefits: effects improve over 12-24 months, low relapse rates, and reduces ketamine frequency. Learn patient selection criteria, Medicare RECOVER trial access at 80+ sites, insurance appeals process, and how VNS creates a clinical "floor" preventing deepest episodes. Expert insights from Dr. Lucian Manu, Stony Brook University.
#27
Oct 23, 2025 · 48 min
Should a Psychiatrist Ever Prescribe a GLP-1? with Brittany Albright, MD, MPH
GLP-1 receptors throughout the brain's reward pathway make these medications psychiatric tools for treating depression and other mental health issues, not just metabolic issues. Learn evidence-based patient selection criteria for treating cravings, compulsivity, and metabolic dysfunction in psychiatric practice with Will Sauvé, MD, and Brittany. Albright, MD, MPH.
#26
Sep 17, 2025 · 53 min
How TMS is Rewiring Psychiatry with Martha Koo, MD
Dr. Martha Koo bought her first TMS machine in 2009 when colleagues thought she was "crazy," and now runs 11 centers as immediate past president of the Clinical TMS Society. Her insights reveal why TMS doesn't require patient belief, how early billing accidentally funded research, and where neuromodulation is headed with accelerated protocols and implantable devices.
#25
Jun 4, 2025 · 47 min
Lifestyle Psychiatry: How Creatine + Exercise Rewires Depressed Brains with Dr. Nicholas Fabiano
New research shows exercise (especially when paired with creatine) can match antidepressants for treating mild-to-moderate depression by triggering muscle proteins that act like "miracle grow for the brain." Dr. Nicholas Fabiano explains how psychiatrists are using systematic exercise protocols and creatine supplementation alongside traditional treatments, plus warning signs when exercise becomes harmful. Learn the FIT framework for prescribing exercise and why the future of mental health care m
#24
Feb 20, 2025 · 56 min
From Crisis to Community: Transforming High-Risk Psychiatric Care Beyond Hospital Walls with Matthew Bernstein, M.D.
After eight years at McLean Hospital's acute unit, Dr. Matt Bernstein chose to treat high-risk psychiatric patients in their communities rather than behind hospital walls. Through his work at Ellenhorn and the innovative Accord Metabolic Psychiatry Program, he demonstrates how combining measurement-based care, metabolic approaches, and meaningful social connection can transform outcomes for complex cases—challenging traditional assumptions about risk and recovery in psychiatry.
#23
Oct 24, 2024 · 23 min
The SPRAVATO® Story with Dr. Hussesini K. Manji,
Dr. Husseini K. Manji reveals the groundbreaking journey of esketamine (SPRAVATO®) from lab to FDA approval. Discover how this rapid-acting antidepressant is reshaping depression treatment and paving the way for future psychedelic medicines.
#21
Sep 26, 2024 · 48 min
How to Build a Breakthrough Treatment Clinic with Charles Miller, CRNA
Charles Miller, CRNA, shares his journey of building Scenic City Neurotherapy from a small startup to a thriving ketamine and TMS clinic. He offers practical advice on patient education, navigating insurance, and overcoming business challenges, providing invaluable insights for clinicians looking to start or expand their own breakthrough treatment practices.
#20
Aug 1, 2024 · 57 min
Will the FDA Approve MDMA-AT?: Experts Weigh In
Explore the complex landscape of MDMA-assisted therapy for PTSD as the FDA's decision looms. Expert panelists discuss key challenges, regulatory hurdles, and the future of psychedelic medicine in mental health treatment.
#19
Jul 24, 2024 · 40 min
Entering Psychiatry's Golden Era with Dr. David Feifel, MD, PhD
Dr. David Feifel, M.D., Ph.D., discusses his transition from studying quantum physics to pioneering ketamine and TMS treatments in psychiatry. He shares insights on combining therapies, overcoming institutional barriers, and expanding access to innovative mental health treatments globally. Learn how these approaches are changing outcomes for treatment-resistant patients and shaping the future of psychiatry.
#18
Jun 18, 2024 · 54 min
Metabolic Psychiatry: Can Ketones Transform Mental Health Treatment?
Discover how the ketogenic diet is transforming mental health treatment through the groundbreaking field of metabolic psychiatry. Explore the science behind changing your diet to change your mind. Learn from leading experts Dr. Georgia Ede and Dr. Bret Scher about implementing metabolic psychiatry in clinical practice to improve patient outcomes, even in cases of treatment-resistant illness.
#17
May 21, 2024 · 52 min
Navigating Adult ADHD and the Stimulant Shortage with Jake Behrens, MD
Enhance your understanding of adult ADHD with Dr. Jake Behrens. Learn practical strategies, innovative tools, and expert insights for better patient outcomes, even during the stimulant shortage. Tune into this essential episode of Psychiatry Tomorrow!
#16
Apr 17, 2024 · 52 min
Moving Interventional Psychiatry Forward with Dr. Rebecca Allen, MD, MPH, President of CTMSS
Dr. Rebecca Allen, President of the Clinical TMS Society, shares insights from growing her clinic that offers treatments like ECT and TMS, while running COMPASS psilocybin clinical trials. Discover how she uses smart partnerships to grow her practice while expanding access to life-saving treatments.
#15
Mar 13, 2024 · 44 min
Safeguard Your Ketamine Clinic: Legal Expertise You Need to Know
Learn how to navigate the legal complexities of ketamine therapy in this enlightening episode of Psychiatry Tomorrow. Legal experts Daniel Sternthal and Ethan Minkin offer invaluable strategies to protect your practice, enhance compliance, and ensure patient safety in the evolving landscape of psychedelic medicine.
#14
Feb 14, 2024 · 50 min
Ketamine, Autism, and Restorative Justice with Bergina Isbell, MD
Discover Dr. Bergina Isbell's innovative approach to mental health, from leveraging ketamine-assisted psychotherapy for neurodiverse individuals to advocating for restorative justice and work-life balance.
#13
Jan 10, 2024 · 50 min
Clinical Trials and Breakthrough Treatments with Michael Banov, MD
Dive into the riveting world of psychiatric clinical trials with Dr. Michael Banov, a triple-board certified expert with over 150 trials under his belt. From the pioneering Clozapine trial to the latest in Vagus Nerve Stimulators, discover the evolution, challenges, and ethical nuances of these groundbreaking studies.

Showing 1–20 of 20 episodes